SCHEMBL28049099

SCHEMBL28049099

CCc1ccc(-c2csc(C(F)(F)F)c2OS(=O)(=O)CC)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTGS2 P35354 3/20 0.34
FFAR4 Q5NUL3 2/20 0.33
PTPN1 P18031 1/20 0.33
PTGS1 P23219 1/20 0.32
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALDH1A1 P00352 2/20 0.31
UCHL1 P09936 1/20 0.31
EGFR P00533 1/20 0.31
ALPI P09923 1/20 0.31
PRKCZ Q05513 1/20 0.31
NPC1 O15118 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28049141 0.88 PTGS2 (0.45) GAAL3MBTL1PTGS2PTGS1PRKCZ
SCHEMBL28049063 0.87 FFAR4 (0.40) GAAL3MBTL1PTGS2FFAR4PTGS1
SCHEMBL28123376 0.86 PTGS2 (0.40) GAAL3MBTL1PTGS2PTPN1PTGS1
SCHEMBL28358513 0.81 PTGS2 (0.38) GAAL3MBTL1PTGS2FFAR4PTPN1
SCHEMBL28354792 0.79 CYP2A6 (0.41) PTGS2PTPN1PTGS1EGFR
SCHEMBL16048887 0.78 PRKCZ (0.45) LMNAPTGS2PTGS1CA12CA2
SCHEMBL28049131 0.77 FFAR4 (0.48) PTGS2FFAR4PTGS1ALPISMN1; SMN2
SCHEMBL28354819 0.76 RAB9A (0.42) PTGS2FFAR4PTGS1NPC1RAB9A
SCHEMBL16048662 0.75 FFAR4 (0.39) LMNAGAAL3MBTL1PTGS2FFAR4
SCHEMBL28123342 0.73 FFAR4 (0.37) L3MBTL1PTGS2FFAR4ALPIPRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105209446-A GPR120 agonists for the treatment of type ii diabetes JANSSEN PHARMACEUTICA NV 2015-12-30 CN disclosed